Danielle Benisvy
Bron, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET.
Journal: ESMO open
Published: September 16, 2025
Loss of neuromonitoring signal in thyroid surgery: predictive factors and surgical strategies.
Journal: World journal of surgical oncology
Published: May 20, 2025
Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial.
Journal: The lancet. Diabetes & endocrinology
Published: June 14, 2024
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 12, 2023
SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : What is the role of functional imaging and isotopic treatment?
Journal: Annales d'endocrinologie
Published: October 23, 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer.
Journal: The New England journal of medicine
Published: March 09, 2022
Intermittent versus continuous administration of pazopanib in progressive radioiodine refractory thyroid carcinoma: Final results of the randomised, multicenter, open-label phase II trial PAZOTHYR.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 09, 2021
18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 02, 2019
Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid Cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: August 15, 2018
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial.
Journal: The lancet. Diabetes & endocrinology
Published: February 21, 2018
Iodinated Contrast Agents Perturb Iodide Uptake by the Thyroid Independently of Free Iodide.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 04, 2017
Last Updated: 09/26/2026